1,507.00
-2.00
(-0.13%)
At close: 3:30:30 PM GMT+9
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ki-Young Sohn | Chairman & Chief Executive Officer | -- | -- | -- |
| Dr. G. Alexander Fleming M.D., Ph.D. | Member of Corporate Advisory Committee & CTO | -- | -- | -- |
| Mr. Do-Young Lee | Chief Scientific Officer & Member of the Board of Directors | -- | -- | -- |
| Myung-Hwan Kim M.D., Ph.D. | CMO & Director | -- | -- | -- |
| Dr. Jeff Clark | Chief Licensing Officer | -- | -- | -- |
| Mr. John Choi | Executive Director | -- | -- | -- |
| Jae-Yong Lee | VP & Executive Director | -- | -- | -- |
Enzychem Lifesciences Corporation
aT Center
10th Floor 27 Gangnamdae-ro Seocho-gu
Seoul
South Korea
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 122
Description
Enzychem Lifesciences Corporation engages in developing novel small molecule therapeutics for patients with unmet needs for oncology, inflammatory, and severe respiratory diseases in South Korea. It is also developing EC-18, an oral small molecule for fibrotic diseases, such as nonalcoholic steatohepatitis; and in severe respiratory diseases as a potential therapy for COVID-19. The company was founded in 1999 and is headquartered in Seoul, South Korea.
Corporate Governance
Enzychem Lifesciences Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 18, 2025 at 10:59 AM UTC - March 24, 2025 at 12:00 PM UTC
Enzychem Lifesciences Corporation Earnings Date
Recent Events
Recent Events Information Not Available